Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRIX

Nurix Therapeutics Inc

Apr 30 • 04:00PM ET

16.70

+0.09 0.54 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: FATE CRSP BMRN EDIT NTLA TVRD BLUE KPTI RGNX PTGX

| Held by: XBI VTI IWM ARKG VXF IWN IBB SCHA VTWO DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.16	Insider Own	5.87%	Shs Outstand	103.40M	Perf Week	0.78%
Market Cap	1.73B	Forward P/E	-	EPS next Y	-2.83	Insider Trans	-1.68%	Shs Float	97.34M	Perf Month	7.74%
Enterprise Value	1.24B	PEG	-	EPS next Q	-0.72	Inst Own	103.59%	Short Float	19.73%	Perf Quarter	-5.06%
Income	-295.28M	P/S	24.06	EPS this Y	3.25%	Inst Trans	26.26%	Short Ratio	17.71	Perf Half Y	40.34%
Sales	71.78M	P/B	3.59	EPS next Y	3.95%	ROA	-47.20%	Short Interest	19.20M	Perf YTD	-11.97%
Book/sh	4.65	P/C	3.19	EPS next 5Y	9.58%	ROE	-61.40%	52W High	22.50 -25.78%	Perf Year	44.84%
Cash/sh	5.23	P/FCF	-	EPS past 3/5Y	6.31% -2.04%	ROIC	-55.05%	52W Low	8.19 103.78%	Perf 3Y	73.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.55% 36.35%	Gross Margin	74.22%	Volatility	4.63% 5.17%	Perf 5Y	-52.04%
Dividend TTM	-	EV/Sales	17.34	EPS Y/Y TTM	-12.53%	Oper. Margin	-439.26%	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.01	Sales Y/Y TTM	27.23%	Profit Margin	-411.37%	RSI (14)	54.05	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	6.01	EPS Q/Q	-17.44%	SMA20	1.48%	Beta	1.90	Target Price	30.18
Payout	-	Debt/Eq	0.12	Sales Q/Q	-66.12%	SMA50	5.44%	Rel Volume	0.78	Prev Close	16.61
Employees	317	LT Debt/Eq	0.12	Earnings	Apr 08 BMO	SMA200	18.63%	Avg Volume	1.08M	Price	16.70
IPO	Jul 24, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.59% -56.13%	Trades		Volume	840,235	Change	0.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)